ID:T3066
ID:T3066PURITY:0.9975
PURITY:0.9975Formula:C17H18N6
Formula:C17H18N6MolWt:360.36
MolWt:360.36Appearance:白色粉末
Appearance:白色粉末Solubility:G4DMSO 61 mg/mL;Water <1 mg/mL
Solubility:G4DMSO 61 mg/mL;Water <1 mg/mLBioactivity:Ruxolitinib (INCB018424) is the first potent, selective, JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM in cell-free assays, >130-fold selectivity for JAK1/2 versus JAK3.
Bioactivity:Ruxolitinib (INCB018424) is the first potent, selective, JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM in cell-free assays, >130-fold selectivity for JAK1/2 versus JAK3.Status:FDA
Status:FDAPathways:JAK/STAT Signaling
Pathways:JAK/STAT SignalingTarget:JAK inhibitor
Target:JAK inhibitorReceptor:JAK1, JAK2
Receptor:JAK1, JAK2